Clinical trial
A Study of Tamiflu (Oseltamivir) Treatment in Laboratory-Confirmed Influenza.
NCT00436124 · Hoffmann-La Roche, Industry · Terminated
Key facts
| NCT number | NCT00436124 |
|---|---|
| Title | A Study of Tamiflu (Oseltamivir) Treatment in Laboratory-Confirmed Influenza. |
| Official title | A Randomized, Open Label Study to Evaluate the Effect of Tamiflu on Viral Shedding and on Serum and Cytoplasmic Inflammatory Cytokine Concentrations in Patients With Laboratory-confirmed Influenza |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Influenza |
| Intervention type | Drug |
| Interventions | oseltamivir [Tamiflu] |
| Start date | Jan 1, 2007 |
| Primary completion | Apr 1, 2007 |
| Completion | Apr 1, 2007 |
| First posted | Feb 16, 2007 |
| Last update posted | Feb 17, 2017 |
| Countries | Italy |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: